logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-02-01 Atea Pharmaceuticals, Inc. Corcoran Andrea
(See Remarks)
S Common Stock D 15843 $3.84 - $3.84 $60,914
2024-02-01 Atea Pharmaceuticals, Inc. Sommadossi Jean-P...
(President, CEO, and Chairman)
S Common Stock D 56910 $3.85 - $3.85 $218,818
2024-02-01 Atea Pharmaceuticals, Inc. Horga Maria Arantxa
(Chief Medical Officer)
S Common Stock D 15870 $3.84 - $3.84 $60,963
2024-02-01 Atea Pharmaceuticals, Inc. Foster Wayne
(EVP, Chief Accounting Officer)
S Common Stock D 12477 $3.84 - $3.84 $47,904
2024-02-01 Atea Pharmaceuticals, Inc. Vavricka John
(Chief Commercial Officer)
S Common Stock D 11819 $3.84 - $3.84 $45,420
2024-02-01 Atea Pharmaceuticals, Inc. Hammond Janet MJ
(Chief Development Officer)
S Common Stock D 14029 $3.84 - $3.84 $53,913
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6